ATC/DDD index J05AF

You are here: Home > ATC/DDD > J > J05 > J05A

Anatomical therapeutic chemical (ATC) classification system

ANTIINFECTIVES FOR SYSTEMIC USE

ANTIVIRALS FOR SYSTEMIC USE

DIRECT ACTING ANTIVIRALS

J05AF

Nucleoside and nucleotide reverse transcriptase inhibitors

ATC/DDD code J05AF for Nucleoside and nucleotide reverse transcriptase inhibitors
The DDDs are based on combination therapy in HIV infections.
The DDD for tenofovir disoproxil is 245 mg and is equivalent to
300 mg tenofovir disoproxil fumarat.
The DDDs for entecavir and telbivudine are based on monotherapy in the treatment of chronic hepatitis B virus infections.

Tenofovir disoproxil

Adefovir dipivoxil

ICD-10

ICD-10-CM 10th Revision 2016
CIE-10 ICD-10 español
ICD-10-GM ICD-10 in Deutsch
МКБ-10 ICD-10 на русском

ATC

ATC/DDD ATC with DDD
ATC ATC español
ATC ATC in Deutsch
АТХ ATC на русском

ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision

ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us